Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
1.500
+0.010 (0.67%)
Sep 2, 2026, 12:25 PM EDT - Market open
Nyxoah Market Cap
Nyxoah has a market cap or net worth of $155.23 million as of September 2, 2026. Its market cap has decreased by -28.77% in one year.
Market Cap
155.23M
Enterprise Value
111.41M
1-Year Change
-28.77%
Ranking
Category
Stock Price
$1.50
ChartMarket Cap Chart
Since the IPO on July 2, 2021, Nyxoah's market cap has decreased from $746.03M to $155.23M, a decrease of -79.19%. That is a compound annual growth rate of -26.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 155.23M | -24.78% |
| Dec 31, 2025 | 206.37M | -35.52% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | -26.92% |
| Jul 2, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanara MedTech | 319.28M |
| Anbio Biotechnology | 305.92M |
| Embecta | 295.76M |
| OraSure Technologies | 245.18M |
| Utah Medical Products | 228.92M |
| Pro-Dex | 196.16M |
| Jin Medical International | 184.32M |
| KORU Medical Systems | 151.91M |